ISO 13485 Medical Devices

ISO 13485 Clause 5.6 mandates formal management review requiring executives to regularly evaluate quality system performance against defined metrics including CAPA status, audit findings, complaint trends, and supplier performance. This transforms quality from a departmental function into a board-level governance responsibility.
ComplianceQuest converts these requirements into live executive dashboards, aggregating CAPA closure rates, nonconformance trends, training compliance, and supplier risk scores into a single real-time view. Rather than receiving quarterly static reports, executives see quality performance continuously. This enables proactive intervention when metrics deteriorate, long before an audit finding or regulatory inspection surfaces the underlying problem.

ISO 13485 certification is the universal market access credential for medical device manufacturers. Canada, Europe under EU MDR, Japan, and Australia all require it as a foundational compliance demonstration. Without certification, growing companies are locked out of the majority of regulated global markets regardless of product quality.
Beyond market access, ISO 13485 provides the quality system infrastructure that scales with growth such as document control, CAPA, supplier management, and training frameworks that prevent the compliance drift that typically derails expanding manufacturers. ComplianceQuest's pre-built ISO 13485-aligned workflows mean growing companies implement a proven, auditable system rather than building quality infrastructure reactively under regulatory pressure.